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Background and Purpose: Arterial diameter is dictated by the contractile state of
the vascular smooth muscle cells (VSMCs), which is modulated by direct and indirect
inputs from endothelial cells (ECs). Modulators of KCNQ-encoded kV7 channels have
considerable impact on arterial diameter and these channels are known to be expressed
in VSMCs but not yet defined in ECs. However, expression of kV7 channels in ECs would
add an extra level of vascular control. This study aims to characterize the expression and
function of KV7 channels within rat mesenteric artery ECs.
Experimental Approach: In rat mesenteric artery, KCNQ transcript and KV7
channel protein expression were determined via RT-qPCR, immunocytochemistry,
immunohistochemistry and immunoelectron microscopy. Wire myography was used to
determine vascular reactivity.
Key Results: KCNQ transcript was identified in isolated ECs and VSMCs. KV7.1, KV7.4
and KV7.5 protein expression was determined in both isolated EC and VSMC and in
whole vessels. Removal of ECs attenuated vasorelaxation to two structurally different
KV7.2-5 activators S-1 and ML213. KIR2 blockers ML133, and BaCl2 also attenuated
S-1 or ML213-mediated vasorelaxation in an endothelium-dependent process. KV7
inhibition attenuated receptor-dependent nitric oxide (NO)-mediated vasorelaxation to
carbachol, but had no impact on relaxation to the NO donor, SNP.
Conclusion and Implications: In rat mesenteric artery ECs, KV7.4 and KV7.5 channels
are expressed, functionally interact with endothelial KIR2.x channels and contribute to
endogenous eNOS-mediated relaxation. This study identifies KV7 channels as novel
functional channels within rat mesenteric ECs and suggests that these channels are
involved in NO release from the endothelium of these vessels.
Keywords: pharmacology, vascular biology, endothelial cell, KV7 channel, KIR channel, carbachol
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INTRODUCTION
KCNQ-encoded KV7 channels are key regulators of arterial
reactivity. Within the vasculature, of the five KCNQ
subtypes, KCNQ4 is predominantly expressed, followed by
KCNQ5 > KCNQ1; with little to no contribution from
KCNQ2/3 (Ohya et al., 2003; Yeung et al., 2007; Ng et al.,
2011). In human and rodent blood vessels KV7 channels
contribute to resting tone (Ohya et al., 2003; Yeung et al.,
2007; Mackie et al., 2008; Ng et al., 2011), whereby their
blockers such as linopirdine or XE991 produce contractions
or enhance vasoconstrictor responses. In addition, a range
of KV7 channel activators including retigabine, S-1 and
ML213 are effective relaxants of pre-contracted arterial tone.
Furthermore, KV7 channels also represent functional end
targets for a myriad of endogenous vasoactive responses,
wherein channel activity is impaired during PKC-mediated
vasoconstriction (Brueggemann et al., 2006) and enhanced as
a result of cGMP and cAMP dependent receptor-mediated
vasodilation (e.g., Chadha et al., 2012; Khanamiri et al., 2013;
Stott et al., 2014, 2015; Mani et al., 2016; Brueggemann
et al., 2018; Mondéjar-Parreño et al., 2019). To date,
vascular KV7 channel studies have focused predominantly
on vascular smooth muscle cells (VSMCs) or whole arteries,
and as a result it is currently unclear whether endothelial
cells (ECs) express KV7 channels and if so, what their
functional role may be.
Endothelial cells form the inner layer of blood vessels and
constitute a paracrine signaling platform which regulates
VSMC contractility, vascular resistance and ultimately blood
flow through the release of nitric oxide (NO), prostacyclin,
epoxyeicosatrienoic acid and others; including the generation
and spread of endothelium-derived hyperpolarization (EDH)
(McGuire et al., 2001). Myoendothelial (ME) projections
within fenestrations (holes) of the internal elastic lamina
(IEL) facilitate the presence gap junctions (MEGJs) at
a proportion of such sites (∼50% in adult rat 1st–3rd
order ‘large’ mesenteric arteries; MA; Sandow et al., 2009)
which permits heterocellular electrochemical coupling
via connexin proteins (Sandow et al., 2012). These sites
enable the transfer of EC-derived signals via the flow of
both small molecules < ∼1 kDa and current between the
cells. In endothelium-dependent relaxation of rat MA, a
fundamental role for small/intermediate conductance calcium-
activated potassium (SKCa and IKCa, respectively; Sandow
Abbreviations: 4-AP, 4-aminopyridine; Acta2, α-smooth muscle actin-2;
CCh, carbachol; cGMP, cyclic guanosine monophosphate; Cq, quantification
cycle; CYC1, cytochrome C1; EC, endothelial cell; EDH, endothelium derived
hyperpolarization; GAPD, glyceraldehyde-3-phosphate dehydrogenase; eNOS,
endothelial nitric oxide synthase; IKCa, intermediate conductance calcium-
activated potassium channel; IEL, internal elastic lamina; KIR, inwardly
rectifying potassium channel; KV, voltage-gated potassium channel; L-NAME,
L-nitroarginine methyl ester; MA, mesenteric artery; MO, methoxamine; Myh11,
myosin heavy chain 11; NO, nitric oxide; PECAM-1, platelet endothelial
cell adhesion molecule-1; RT-qPCR, reverse-transcription quantitative
polymerase chain reaction; SEM, standard error of the mean; SKCa, small
conductance calcium-activated potassium channel; SNP, S-nitroprusside;
TEA, tetraethylammonium; VSMC, vascular smooth muscle cell; vWBF,
von-Willebrand factor.
et al., 2006; Dora et al., 2008), transient receptor potential
canonical type 3 (Senadheera et al., 2012), inwardly rectifying
potassium channels (KIR2) (Goto et al., 2004), as well as
inositol-1,3,4 trisphosphate receptor/s (Fukao et al., 1997) has
been demonstrated.
Identification of KV7 expression in ECs would open
up a new layer of vascular control by these channels
and is a necessary requisite for understanding the role
of these channels in vascular health and disease. This
study aims to ascertain whether rat mesenteric ECs
express KV7 channels, and if so, what their functional
implications may be. This study shows that KV7 channels
are expressed in rat mesenteric artery ECs and contribute
to both KV7 activator-mediated relaxation via a potential
functional interaction with KIR2 channels and endothelial




Experiments were performed on MA from Male Wistar rats
(Charles River, Margate, United Kingdom) ages 11–14 weeks
(200–350 g) from the Biological Research Facility, St George’s,
London, United Kingdom; and from the Animal Resources
Center, Perth, Australia. Animals were housed in cages with
free access to water and food (RM1; Dietex Inter-national,
United Kingdom) ad libitum, with a 12-h light/dark cycle and
constant temperature and humidity (21 ± 1◦C; 50% ± 10%
humidity) in accordance with the Animal (Scientific Procedures)
Act 1986, the guidelines of the National Health and Medical
Research Council of Australia and the UNSW Animal Ethics
and Experimentation Committee (AEEC #18/86B). Animals were
kept in LSB Aspen woodchip bedding. Animals were culled
by either cervical dislocation with secondary confirmation via
cessation of the circulation by femoral artery severance or were
anesthetized with sodium pentathol (intraperitoneal, 100 mg/kg)
in accordance with Schedule 1 of the ASPA 1986.
Either whole mesenteric plexus or 2nd/3rd/4th order MA were
used with vessel order identified from the second bifurcation
of the superior MA. Arteries were dissected, cleaned of fat
and adherent tissue and stored on ice within physiological salt
solution (PSS) of the following composition (mmol-L−1); 119
NaCl, 4.5 KCl, 1.17 MgSO4.7H20, 1.18 NaH2PO4, 25 NaHCO3,
5 glucose, 1.25 CaCl2.
Reverse Transcription Quantitative
Polymerase Chain Reaction
Second and third order MA segments were enzymatically
digested to obtain either freshly isolated ECs (as previous,
Greenberg et al., 2016) or VSMCs. Briefly, vessels were washed
in Hanks’ Balanced Salt Solution (HBSS; ThermoFisher Scientific,
GIBCO, 14170-088) containing 50 µmol-L−1 CaCl2 for 5 min at
37◦C, the media was then replaced in HBSS containing 50 µmol-
L−1 CaCl2 with 1 mg/mL collagenase IA (Sigma Aldrich, C9891,
United Kingdom) for 15 min at 37◦C. Vessels were washed
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in HBSS containing 50 µmol-L−1 CaCl2 for 10 min at 37◦C.
The supernatant was removed and the vessels suspended in
fresh HBSS containing 75 µmol-L−1 CaCl2. For RT-qPCR,
ECs were dissociated using a wide-bore smooth-tipped pipette
and identified under the microscope (x10) as sheets of cells
independent from the vessel which were harvested and stored
separately from the residual VSMCs.
mRNA from both isolated ECs and VSMCs was extracted
using Monarch Total RNA Miniprep Kit (New England
BioLabs, Ipswich, MA, United States) and reverse transcribed
via LunaScript RT SuperMix Kit (New England BioLabs,
Ipswich, MA, United States). Quantitative analysis of relative
gene expression was assessed via CFX-96 Real-Time PCR
Detection System (BioRad, Hertfordshire, United Kingdom).
Samples were run in duplicate to account for variation.
Samples were run in BrightWhite qPCR plate (Primer Design,
Camberley, United Kingdom), with each well containing 20 µL
of reaction solution containing: 10 µL of PrecisionPLUS qPCR
Master Mix (Primer Design, Camberley, United Kingdom),
300 nmol-L−1 of gene specific target primer (Thermofisher
scientific, Waltham, MA, United States) and 10 ng of cDNA
sample made up to 20 µL total volume with nuclease free
water. Run protocol: (1) activation step (15 min:95◦C), (2)
denaturation step (15 s: 94◦C), (3) annealing step (30 s:
55◦C), and (4) extension step (30 s: 70◦C). Steps 2- 4 were
repeated x 40. Quantification cycle (Cq) was determined via
Bio-Rad CFX96 Manager 3.0. Cq values were normalised to
housekeeper genes expressed as a 2−1Cq when compared to
appropriate reference genes including 14-3-3 Zeta (YWHAZ)
and glyceraldehyde-3-phosphate dehydrogenase (GAPD). Cell
isolation for VSMCs and ECs was validated by either positive
expression of VSMC specific marker α-actin 2 (Acta2) or EC
specific marker-platelet endothelial cell adhesion molecule-1
(Pecam-1) respectively. See Table 1 for a list of the primers used
in the following (Jepps et al., 2011; Askew Page et al., 2019;
ThermoFisher Scientific).
TABLE 1 | RT-qPCR primer sequences.




(−) Reverse primer sequence
Acta2 ATCCGATAGAACACGGCATC NM_031004.2 228
AGGCATAGAGGGACAGCACA
Pecam1 CTCCTAAGAGCAAAGAGCAACTTC NM_031591.1 100
TACACTGGTATTCCATGTCTCTGG
Kcnq1 TGGGTCTCATCTTCTCCTCC NM_032073 124
GTAGCCAATGGTGGTGACTG
Kcnq2 AAGAGCAGCATCGGCAAAAA NM_133322 101
GGTGCGTGAGAGGTTAGTAGCA-
Kcnq3 CAGCAAAGAACTCATCACCG AF091247 161
ATGGTGGCCAGTGTGATCAG
Kcnq4 GAATGAGCAGCTCCCAGAAG XM_233477.8 133
AAGCTCCAGCTTTTCTGCAC
Kcnq5 AACTGATGAGGAGGTCGGTG XM_001071249.3 120
GATGACCGTGACCTTCCAGT
Immunocytochemistry
Freshly dispersed ECs (as above), together with residual VSMCs
were left for 1hr before use. Cells were then fixed in 4%
paraformaldehyde (Sigma-Aldrich, United Kingdom) in PBS for
20 min at RT as previously described (Barrese et al., 2018a). Cells
were treated with 0.1 mol-L−1 glycine for 5 min and incubated
for 1 h with blocking solution (PBS-0.1% Triton X-100-10%
bovine serum albumin) at RT. Following incubation overnight
at 4◦C with primary antibodies (Table 2) diluted in blocking
solution (anti-PECAM-1 for ECs, anti-α-actin for VSMCs and
anti-KV7.1, KV7.4, and KV7.5 channel for ECs/VSMCs), cells
were then washed for 20 min with PBS, incubated for 1 h
at RT with the secondary conjugated antibodies diluted in
blocking solution. Excess secondary antibody was removed by
washing with PBS and cells mounted using media containing 4′,6-
diamidino-2-phenylindole (DAPI) for nuclear counterstaining.
Using triple staining, ECs and VSMC were differentiated via the
following: ECs were positive for anti PECAM-1 and negative
for anti-α-actin; while VSMC was positive for anti-α-actin
and negative for anti-PECAM-1 (data not shown). Cells were
analyzed using a Zeiss LSM 510 Meta argon/krypton laser
scanning confocal microscope (Image Resource Facility, St
George’s University, London).
Cell Culture
Chinese Hamster Ovary (CHO) cells were maintained in DMEM
supplemented with 10% fetal bovine serum, 2 mmol-L−1 L-
glutamine, and 1% penicillin/streptomycin (Sigma Aldrich,
Dorset, United Kingdom) and maintained at 37◦C with 5%
CO2 in an incubator. Cells were plated in a 24-well plate,
incubated for 24hr then transfected with either KV7.1, KV7.4 or
KV7.5 plasmids using Lipofecamine 2000 (Thermofisher, Paisley,
United Kingdom) as described previously (Barrese et al., 2018a).
After 24 h, cells were fixed and stained as described above.
Immunohistochemistry
Animals were anesthetized with sodium pentathol
(intraperitoneal, 100 mg/kg) and perfusion fixed (Sandow
et al., 2004) in 2% paraformaldehyde in 0.1 mol-L−1 PBS. Third
to 4th order MA segments were dissected, opened laterally and
pinned as a sheet to a Sylgard dish. Segments were washed in
PBS (3 × 5 min), incubated in blocking buffer (PBS with 1%
BSA and 0.2% Triton) at room temperature (RT) for 2 h and
then overnight with primary antibody (Table 2) in blocking
buffer at 4◦C, washed again (3 × 5 min with gentle agitation),
and incubated in secondary antibody (Table 2; matched to the
respective primary) in PBS with 0.1% Triton in PBS for 2 h at
RT. Tissue was mounted on slides in anti-fade media containing
propidium iodide (PI) or DAPI (Table 2) and imaged with
uniform confocal settings. Incubation of tissue with secondary
only was used as a ‘zero’ setting for confocal imaging. Controls
involved substitution of primary with isotype control, with
concentration (where provided by manufacturer) matched, or
10-fold higher than the respective antibody of interest (Table 2).
Working Ab dilutions were prepared in accordance with previous
work (Jepps et al., 2009; Chadha et al., 2012). Confocal image





















TABLE 2 | Immunocyto/histochemistry reagents and use (Jepps et al., 2009; Chadha et al., 2012).





Primary antibodies Kv7.1/KCNQ1 Pineda Antikörper-Service, Germany 75 N-terminus 1:100 No Rabbit
Kv7.4/KCNQ4 NeuroMab, cat no 75-082, 1 mg/ml 77 Hu aa 2-77, clone N4/36 IgG 1:200 (5 µg/ml) No Mouse
Kv7.4/KCNQ4* Abcam, ab65797, lot GR94754, whole serum 77 N’ domain 1:100 not available No Rabbit
Kv7.5/KCNQ5* Millipore ABN1372-q2476155; 1 ml/ml ∼103 Human IgG 1:100 (10 µg/ml) No Rabbit
PECAM-1/CD31 Santa Cruz Biotechnology, Sc-1506, 200 µg/ml 130 699–727 aa at the C-terminus 1:100 (2 µg/ml) – Goat
SM-α-actin Sigma Aldrich A2547 ∼42 N-terminal (1:100) not available – Mouse
Nuclear labels/cell patency
markers
DAPI, Vectasheild Vectorlabs – Nucleic acid – –
propidium iodide (PI) Sigma, P4170 – Nucleic acid 10 nM – –
Immuno-histochemistry
secondary antibodies
Mouse 568 Abcam, ab175700, lot GR320062-4, 2 mg/ml – IgG 1:100 (20 µg/ml) – Donkey
Rabbit 546 Thermofisher, A-11035 – IgG 1:100 (20 µg/ml) – Goat
Rabbit 633 Merck, SAB4600132, lot 15C0423, 2 mg/ml – IgG 1:100 (20 µg/ml) – Donkey
Immuno-cytochemistry
secondary antibodies
Mouse 488 Thermofisher, A21202, 2 mg/mL – IgG 1:100 (0.02 mg/ml) – Donkey
Rabbit 568 Thermofisher, A10042, 2 mg/mL – IgG 1:100 (0.02 mg/ml) – Donkey
Goat 633 Thermofisher, A21082, 2 mg/mL – IgG 1:100 (0.02 mg/ml) – Donkey
Isotype controls Mouse IgG ThermoFisher, 10400C – IgG 5 mg/ml – Mouse
Rabbit IgG ThermoFisher, S31235 – IgG 10 mg/ml – Rabbit
Immunoelectron microscopy
secondary antibodies
5 nm Au anti- rabbit Merck, G7277, lot SLB3882V – IgG 1:100 – Goat
10 nm Au anti- rabbit Merck, G7402 – IgG 1:100 – Goat
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FIGURE 1 | Expression profile of Kcnq genes within isolated rat mesenteric vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). RT-qPCR analysis of
relative expression of Kcnq1-5 in isolated VSMCs and ECs (A). Cell specific markers Acta2 and Pecam, for VSMCs and ECs respectively, were measured to
determine sample purity (B,C). Values expressed as mean ± SEM of (2−1Cq) of 1Cq values generated from appropriate housekeeper genes (n = 3). Statistical
significance is defined as *P < 0.05 (B,C).
stacks were collected at 0.2 µm intervals. The optimal rinsing
protocol was determined by incubating in secondary only; and
rinsing after successive 5 min incubations until fluorescence was
reduced to background. Note that if this was not done secondary
alone was specifically and highly localized to IEL hole sites; as
potential false positives at such sites; suggesting that such sites
have an affinity for IgG-secondary label alone.
Electron Microscopy
Animals were anesthetized as above and perfusion fixed in
0.2% glutaraldehyde and 2% paraformaldehyde in 0.1 mol-
L−1 PBS (pH 7.4). MA segments (∼2 mm in length) were
washed (3 × 5 min) and processed in a Leica EMPACT
2 high-pressure freezer using 0.7% low melting agarose as
a cryoprotectant. Samples were then freeze-substituted in a
Leica AFS2 into 0.2% uranyl acetate in 95% acetone (from
−85 to −50◦C) and infiltrated with Lowicryl (at −50◦C),
before UV polymerization (2 days each at −50 and 20◦C;
Zechariah et al., 2020). Conventional transmission electron
microscopy (TEM) was conducted using standard procedures
(Sandow et al., 2002, 2004).
Individual serial transverse sections (∼100 nm) were mounted
on Formvar-coated slot grids and processed for antigen
localization as for confocal immunohistochemistry (per above
and Table 2). The secondary used was 5 or 10 nmol-L−1 colloidal
gold-conjugated antibody (1:40; 2 h) in 0.01% Tween-20. Sections
were imaged at x10-40,000 on a JEOL transmission electron
microscope at 16 MP (Emsis, Morada G3). Background gold label
density was determined from randomly selected (4x) 1 × 1 µm
regions per sample of lumen and IEL, compared to the same sized
regions of interest in EC profiles.
Wire Myography
Second order MA segments (∼2 mm in length) were mounted
on 40 µm diameter tungsten wire in a tension myograph
chamber (Danish Myo Technology, Arhus, Denmark) containing
5 mL of PSS (composition, as above) oxygenated with
95% O2 and 5% CO2 at 37◦C. Vessels then underwent a
passive force normalization process to achieve an internal
luminal circumference at a transmural pressure of 100 mmHg
(13.3 kPa) to standardize pre-experimental conditions (Mulvany
and Halpern, 1976). Force generated was first amplified
by a PowerLab (ADInstruments, Oxford, United Kingdom),
and recorded by LabChart software (ADInstruments, Oxford,
United Kingdom). Vessels were then challenged with 60 mmol-
L−1 [K+] to determine viability, and then constricted with
10 µmol-L−1 methoxamine (MO), an α-1 adrenoreceptor
agonist, EC integrity was then determined via addition of
10 µmol-L−1 carbachol (CCh), a synthetic acetylcholine analog.
Vessels displaying ≥ 90% vasorelaxation in response to CCh
were considered EC positive (EC+). Vessels were denuded of
ECs by gently passing a human hair through the lumen. Vessels
expressing ≤ 10% vasorelaxation in response to CCh were
considered EC negative (EC−). During functional investigations,
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FIGURE 2 | Immunocytochemistry demonstrates KV7.1, KV7.4, and 7V.5 localization in rat mesenteric artery isolated endothelial (EC; A,C,E) and smooth muscle
cells (SMC; B,D,F). Punctate labelling for Kv7.1, Kv7.4, and 7.5 was present in isolated EC and SMCs (A,C,E and B,D,F). PECAM and smooth muscle a-actin were
used as markers for isolated endothelial and smooth muscle cells, respectively (Ai,Ci,Ei and Bi,Di,Fi respectively); e.g. comparative-same cells, double arrows,
A–Fi). 4′,6-diamidino-2-phenylindole (DAPI; e.g. inset, C) were used as nuclear markers to verify cell patency. n = 4–6, representative of different source tissue
(A–Fi). Double arrows from insets indicate same panel as main, but to different marker.
all vessels were pre-constricted with the thromboxane A2
receptor agonist U46619 (300 nmol-L−1) to elicit an EC80
contraction. Concentration-dependent relaxant responses to S-1
(0.1–10 µmol-L−1), ML213 (0.1–10 µmol-L−1), ML277 (0.03–10
µmol-L−1), CCh (0.3–10 µmol-L−1) and S-nitroprusside (SNP;
0.01–3 µmol-L−1) were determined in the presence and absence
of ECs, linopirdine (10 µmol-L−1), HMR-1556 (10 µmol-L−1),
carbenoxolone (100 µmol-L−1), ML133 (20 µmol-L−1), barium
chloride (BaCl2; 100 µmol-L−1), L-nitroarginine methyl ester
(L-NAME; 100 µmol-L−1), TRAM34 (1 µmol-L−1), Apamin
(10 nmol-L−1), 4-aminopyridine (4-AP; 1 mmol-L−1), and
tetraethylamonium (TEA; 1 mmol-L−1).
Data and Statistical Analysis
All functional figures express mean data from at least 5
animals ± standard error of the mean (SEM). Experiments
comparing groups of unequal numbers are present due to
technical failure or expiry of tissue during isometric tension
recording. For functional experiments involving cumulative
concentrations, a transformed data set was generated using;
X = Log(X), to reduce representative skew. A four parametric
linear regression analysis was then performed using the following
equation; [Log(Agonist) vs. response – variable slope (four
parameters bottom/hillslope/top/EC50)] using GraphPad Prism
(Version 8.2.0) to fit a concentration effect curve (CEC) to the
figure. For data comparing multiple groups, a two way-ANOVA
followed by a post hoc Bonferonni test in order to account for type
1 errors in multiple comparisons was performed for comparison
of mean values. For data comparing two groups, an unpaired
parametric T-test was was performed. Significance values are
represented as follows; P < 0.05 (∗). n = (x), number of animals
used. N = (x), number of segments used. The data and statistical
analysis comply with the recommendations on experimental
design and analysis in pharmacology (Curtis et al., 2018).
RESULTS
Identification of KV7 Channels Within MA
ECs
Initial investigation sought to identify Kcnq/KV7 transcript and
protein within MA ECs. Transcript levels for Kcnq1-5 and EC
and VSMC markers were determined in cell lysates from isolated
MA VSMC and EC (per Methods). Both ECs and VSMCs
expressed Kcnq4 > Kcnq5 > Kcnq1 with no expression of
Kcnq2/3 (Figure 1A) similar to previous studies (Ohya et al.,
2003; Yeung et al., 2007; Ng et al., 2011). However, a comparative
reduction in the relative abundance of Kcnq1 was observed in
MA ECs when compared to VSMCs (Figure 1A). Cell isolation
efficiency is demonstrated by a reduction in EC marker Pecam
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within VSMCs cell lysates when compared to ECs (P ≤ 0.05)
and a reduction in VSMCs marker Acta2 in EC cell lysates when
compared to VSMCs (P = 0.065, Figures 1B,C).
KV7.1, KV7.4, and KV7.5 were detected in isolated ECs
by immunodetection (Figures 2A,C,E). KV7.4 had a punctate
distribution in isolated ECs (Figure 2C) whereas KV7.5 label
appeared to be predominantly cytoplasmic with some diffuse
label around the nucleus (Figure 2E). Similar to previous
reports (Zhong et al., 2010; Oliveras et al., 2014; Mills et al.,
2015; Morales-Cano et al., 2015; Barrese et al., 2018a). KV7.1,
KV7.4, and 7.5 were also identified in isolated MA VSMCs
(Figures 2B,D,F). Kv7.1 staining in ECs was negligible compared
to VMSCs (Figures 2A,B). ECs and VSMCs were identified
by positive expression of either PECAM (Figures 2Ai,Ci,Ei)
or α-actin (Figures 2Bi,Di,Fi) respectively. Antibody specificity
was determined via positive staining in CHO cells transfected
with purported target and negative staining in non-transfected
control cells (Supplementary Figure 1). Importantly, as ion
channel expression can alter in isolated cells KV7.4 and KV7.5
were also detected in both ECs and VSMCs in en face whole-
mount arteries (Figures 3A,B,E,F). Notably, both KV7.4 and
7.5 were expressed at a proportion of IEL hole sites at an
apparently higher level than the associated EC membrane label
(Figures 3C,D,G,H). We also detected KV7.4 and KV7.5 in EC by
immuno-gold electron microscopy (Supplementary Figure 2).
These studies identify KV7.4 and KV7.5 in ECs as well as
smooth muscle cells.
Removal of ECs Modulates KV7.2-5
Activator Efficacy
A comprehensive pharmacological analysis was undertaken to
determine if KV7 channels have a functional role in MA
ECs via a reductive approach. Initially, the effects of KV7
channel modulators were examined in endothelium intact or
denuded MAs. The structurally dissimilar KV7.2–7.5 activators
S-1 and ML213 interact with the same pharmacophore centered
around a tryptophan in the S5 domain (Schenzer, 2005;
Bentzen et al., 2006; Brueggemann et al., 2014; Jepps et al.,
2014). ML277 is a potent activator of KV7.1 (Yu et al., 2013)
with a 100-fold increase in selectivity for KV7.1 compared to
KV7.2-5 (Yu et al., 2013). Consistent with previous findings
(Chadha et al., 2012; Jepps et al., 2014), S-1- and ML213-
mediated vasorelaxation was ablated by pre-incubation with
10 µmol-L−1 of the pan-KV7 channel inhibitor linopirdine
(Schnee and Brown, 1998; Figures 4A,B,D). Relaxation produced
by 10–300 nmol-L−1 ML277 were also prevented by pre-
incubation with linopirdine (Figure 4C). However, relaxation
produced by concentrations > 1 µmol-L−1 ML277 was not
attenuated by linopirdine and are therefore not mediated by
KV7.1 activation.
Endothelial removal for the following experiments was
confirmed by ablation of vasorelaxation in response to 10 µmol-
L−1 CCh (Figure 5A). Endothelium denudation by mechanical
abrasion has no impact on the peak contraction produced by
300 nmol-L−1 U46619 (Figure 5B), but significantly attenuated
the potency of S-1 mediated vasorelaxation increasing EC50 from
FIGURE 3 | Immunohistochemistry demonstrates Kv7.4 and 7.5 localization
in rat mesenteric artery endothelium (EC) and smooth muscle cells (SMCs)
with a focus on internal elastic lamina (IEL) hole sites in whole mount tissue.
Whole mounts of confocal stacks through the EC and SMC of Kv7.4 (A,B,
respectively) and Kv7.5 (E,F, respectively). Confocal image stacks through the
luminal EC to SM border (C,G) show diffuse/punctate Kv7.4/KV7.5 across the
cell membrane with some punctate higher-level fluorescence at localized sites
(e.g. full arrows; C). When single images were taken at the EC-IEL-SM
interface (D,H), punctate higher-level fluorescence densities were present (e.g.
D,H arrows; H, higher magnification inset) at a proportion of IEL hole sites
(e.g., D,H arrowheads). Propidium iodide (PI; e.g., upper left inset, A,B) were
used as nuclear markers to verify cell and layer patency. Incubation in
secondary only separately for each of the 3 fluorophores (Table 2; e.g. lower
left inset, B; inset, F) were used to set ‘zero’ confocal settings. Incubation in
isotype IgG control only (e.g., E, inset) showed fluorescence equivalent to
secondary alone (e.g., B, lower inset; F, inset). n = 4, representative of
different source. Longitudinal vessel axis, left to right. Double arrows indicate
same site, but at different focal planes (C,D,G,H), and location of inset (D).
Bar, 25 µm.
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FIGURE 4 | Sensitivity of Kv7 activator relaxations to 10 µmol-L−1 linopirdine. In vessels pre-incubated in DMSO solvent control, KV7.2-5 channel activators S-1
and ML213 relax pre-constricted arterial tone (300 nmol-L−1 U46619; black) and are ablated by pre-incubation with pan KV7 channel inhibitor linopirdine
(10 µmol-L−1; gray; n = 5; A,B). In vessels pre-incubated in DMSO solvent control, KV7.1 channel activator ML277 relaxes pre-constricted arterial tone
(300 mol-L−1 U46619; black) and is ablated by linopirdine (10 µmol-L−1; gray) to a threshold of 300 nmol-L−1 ML277 (n = 5; C). A representative trace of
S-1-mediated vasorelaxation ± 10 µmol-L−1 linopirdine (D). All values are expressed as mean + SEM. A two-way statistical ANOVA with a post hoc Bonferroni test
was used to generate significance values. Statistical significance is defined as *P < 0.05 (A–C).
2 ± 0.2 µmol-L−1 to 3 ± 0.7 µmol-L−1 (Figures 5C,D). S-
1 mediated relaxation was also impaired via the non-selective
gap junction inhibitor carbenoxolone (Tare et al., 2002) (water
Emax = 6.11 ± 1.82% vs. carbenoxolone Emax = 18.7 ± 3.25%;
Figure 5E). In addition, the potency of ML213 was also
impaired by endothelial removal (EC(+) EC50 = 1 ± 0.2 µmol-
L−1 vs. EC(−) EC50 = 3 ± 0.2 µmol-L−1; Figure 5F) in a
fashion analogous to S-1. However, the linopirdine-sensitive
relaxation produced by ML277 was not affected by endothelial
removal (Figure 5G).
EC KIR Channels Modulate KV7.2-5
Activator Sensitivity
Having identified that the presence of the endothelium
modulates responses to KV7 activators, experiments were
performed to identify the underlying mechanism/s involved.
Murine endothelial KCNJ2-encoded KIR2.1 channels have been
identified as ‘signal boosters’ that enhance EC-derived relaxation
(Sonkusare et al., 2016). Comparatively, the current literature
regarding rat mesenteric KIR2 channels is limited. In brief,
rat MA endothelium expresses KIR2.1 (Dora et al., 2008),
inwardly rectifying Ba2+ sensitive channels are restricted to
the endothelial layer (Crane et al., 2003a) and KIR channels
contribute to acetylcholine-mediated responses (Goto et al.,
2004). We propose that like mice, rat mesenteric ECs express
functional KIR2 channels that propagate EC signals in a similar
process. Therefore, we performed a series of studies investigating
the effect of two characterized KIR2 blockers, BaCl2 (Hagiwara
et al., 1978) and ML133 (Wang et al., 2011) on KV7 activator-
mediated vasorelaxation.
In arteries with a functional endothelium, KIR2 blockers,
BaCl2 (100 µmol-L−1) and ML133 (20 µmol-L−1), significantly
impaired relaxations produced by S-1 (Figure 6A, EC50 = DMSO,
1.89 ± 0.2 µmol-L−1/BaCl2, 2.3 ± 0.31 µmol-L−1;
Figure 6B, EC50 = DMSO, 0.52 ± 0.12 µmol-L−1/ML133,
3.1 ± 1.5 µmol-L−1) and ML213 (Figures 6C,D, EC50 = DMSO,
0.9 ± 0.3 µmol/L−1/BaCl2, 2.2 ± 0.5 µmol/L−1/ML133,
2.5± 0.25 µmol-L−1) when compared to DMSO solvent control
(Figures 6A–D). No attenuation of the response to ML277 was
observed when pre-incubated with either blocker (Figures 6E,F),
consistent with EC removal. Furthermore, in arteries where the
endothelium had been removed neither ML133 nor BaCl2 had
any effect on ML213 mediated relaxations (Figures 6G,H).
IKCa/SKCa Inhibitors Had No Impact on
KV7 Activator Mediated Relaxation
Endothelial IKCa and SKCa channels contribute to relaxation
responses in rat MA (Crane et al., 2003b). Thus, it is feasible
that KV7 channels interact with other key endothelial
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FIGURE 5 | KV7.2-5 channel activator mediated vasorelaxation was significantly attenuated by EC removal. Removal of ECs ablated vasorelaxation in response to
10 µmol-L−1 CCh following pre-constriction with 10 µmol-L−1 MO (A). Removal of ECs (gray) has no effect on vasoconstriction to U46619 (300 nmol-L−1) when
normalized to vasoconstriction to KCl (60 mmol-L−1; n = 5–7; n = 15-21; B). Representative trace of EC S-1-mediated vasorelaxation in EC(–) denuded vessels
(gray) vs. EC(+) vessels (black; C). S-1-mediated vasorelaxation was significantly attenuated by EC removal and 100 µmolL−1 carbenoxolone (gray; n = 5–7; D,E).
ML213 but not ML277-mediated vasorelaxation was significantly attenuated by EC removal (gray; n = 5–7; D,E). Removal of ECs (gray) has no effect on ML277
within its range of linopirdine sensitivity (n = 5; F). All values are expressed as mean + SEM (A–G). A two-way statistical ANOVA with a post hoc Bonferroni test was
used to generate significance values. Statistical significance is defined as *P < 0.05 (A–G).
potassium channels; particularly those expressed within
microdomains (Sandow et al., 2009). However, consistent
with previous reports (Jepps et al., 2016), pre-incubation with
a combination of IKCa inhibitor TRAM-34 (1 µmol-L−1;
Wulff et al., 2000) and SKCa inhibitor apamin (100 nmol-L−1;
Spoerri et al., 1975) had no effect on KV7 activator mediated
vasorelaxation (Figures 7A–C). These data suggest that
the endothelium-dependent increase in potency to the
KV7 activators involves endothelial KIR, but not IKCa or
SKCa channels.
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FIGURE 6 | KV7.2-5 channel activator-mediated vasorelaxation was attenuated by two structurally different KIR channel blockers, BaCl2 and ML133, but not In EC
denuded vessels. KV7.2-5 channel activator S-1 and ML213 effects were significantly attenuated by pre-incubation with the KIR2 channel inhibitor BaCl2
(100 µmol-L−1; black; n = 5–7; A,C). KV7.2-5 channel activator S-1 and ML213 effects were significantly attenuated by pre-incubation with a selective KIr 2.1
channel inhibitor, ML133 (20 µmol-L−1; gray; n = 5–7; B,D). KV7.1 channel activator ML277-mediated vasorelaxation was not affected by pre-incubation with either
BaCl2 (100 µmol-L−1) or ML133 (20 µmol-L−1; gray; n = 6–7; E,F). In EC denuded vessels, KV7.2-5 channel activator ML213 responses were not affected by
pre-incubation with either KIR2 channel inhibitor BaCl2 (100 µmol-L−1; gray; n = 5; G) or ML133 (20 µmol-L−1; gray; n = 5–6; H). All values are expressed as
mean + SEM (A–H). A two-way statistical ANOVA with a post hoc Bonferroni test was used to generate significance values. Statistical significance is defined as
*P < 0.05 (A–H).
KV7 Channels Contribute to CCh Evoked
Vasorelaxation
The expression of functional KV7 channels within ECs begs
the question - do they contribute to EC-derived responses?
Acetylcholine produces endothelium-dependent relaxation
through NO-, EDH- and prostanoid-dependent mechanisms
in rat MA (Parsons et al., 1994; Shimokawa et al., 1996;
Peredo et al., 1997).
A distinct rightward shift in the sensitivity to vasorelaxation
in response to CCh, a synthetic acetylcholine analog, was
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FIGURE 7 | KV7 channel activator mediated vasorelaxation was not affected by preincubation with IKCa/SKCa channel antagonists. Pre-incubation with both IKCa
channel inhibitor TRAM34 (1 µmol-L−1) and SKCa channel inhibitor Apamin (100 nmol-L−1) had no effect on S-1, ML213 nor ML277 mediated vasorelaxation
(n = 5–7; gray, A–C). All values are expressed are expressed as mean values ± SEM. A two-way statistical ANOVA with a post hoc Bonferroni test was used to
generate significance values; no significant values were observed (A–C).
produced by the eNOS inhibitor L-NAME (100 µmol-L−1) when
compared to DMSO control (EC50 DMSO = 0.59 ± 0.1 µmol-
L−1; L-NAME = 0.94 ± 0.1 µmol-L−1; Figure 8A).
A combination IKCa and SKCa inhibitors, TRAM-34 (1 µmol-
L−1) and apamin (100 nmol-L−1) respectively, suppress
EDH in rat MA, and produced greater attenuation (EC50
TRAM34/apamin = 1.5 ± 0.7 µmol-L−1; Figure 8A) when
compared to L-NAME. Pre-incubating vessels with the pan
KV7 channel inhibitor linopirdine (10 µmol-L−1) significantly
attenuated CCh-mediated relaxation when compared to
DMSO control (EC50 DMSO = 0.2 ± 0.08 µmol-L−1;
linopirdine = 0.7 ± 0.3 µmol-L−1; Figure 8B). In contrast,
pre-incubating vessels with either the KV7.1 specific inhibitor
HMR-1556 (10 µmol-L−1) or a combination of non-specific KV
channel inhibitors TEA (1 mmol-L−1; Choi et al., 1991) and
4-AP (1 mmol-L−1; Kurata and Fedida, 2006) had no significant
effect on CCh-evoked vasorelaxation (Figures 8C,D).
Additionally, CCh-evoked relaxations were significantly
attenuated in vessels pre-incubated in TRAM34/apamin
(1 µmol-L−1/100 nmol-L−1) and linopirdine (10 µmol-
L−1) compared to vessels only pre-incubated in
TRAM34/apamin alone (EC50 DMSO = 0.24 ± 0.05 µmol-
L−1; TRAM34/Apamin = 0.27 ± 0.03 µmol-L−1;
TRAM34/Apamin + linopirdine = 0.61 ± 0.2 µmol-L−1;
Figure 8E). In contrast, linopirdine failed to attenuate CCh
relaxation in arteries pre-incubated with L-NAME (100 µmol-
L−1; Figure 8F), thus suggesting KV7 contribution to eNOS
sensitive proportion of CCh-mediated relaxation.
Furthermore, the present data demonstrates that pre-
incubation with linopirdine (10 µmol-L−1) has no effect on
vasorelaxation produced by the NO-donor SNP (Figure 8G).
However, in contrast with previous reports (Jepps et al., 2016),
pre-incubation with L-NAME (100 µmol-L−1) significantly
attenuated KV7.2-5 activator mediated vasorelaxation
(Figure 8H).
DISCUSSION
The present study identified Kcnq1, Kcnq4, and Kcnq5 transcripts
in EC marker expressing cells and the consequent KV7.1,
KV7.4, and KV7.5 protein in isolated and whole mount rat MA
ECs/VSMCs. Functionally, the present study demonstrates that
the relaxation produced by two structurally different KV7.2-
5 activators, but not a KV7.1 activator, were modulated by
the presence of the endothelium and gap junction inhibition.
Said relaxation was also sensitive to KIR2 inhibition, which
was dependent on the presence of ECs, suggestive of a
novel functional interaction between KV7 and endothelial
KIR2.x channels. Furthermore, the present data suggest that
KV7.4/KV7.5 channels contribute to the NO-mediated axis
of CCh-evoked endothelium-dependent relaxation downstream
of eNOS. Thus, KV7 channels are expressed in ECs, when
pharmacologically upregulated, are functionally coupled to
other EC potassium channels in rat MA and contribute to
endothelium-derived responses.
KV7 Channel Expression and Function
Within ECs
Kv7 channel modulators have considerable impact on arterial
tone. In VSMCs, active KV7 channels hyperpolarize the
membrane potential, decreasing voltage-dependent calcium
channel (VDCC) open probability and extracellular calcium
influx resulting in relaxation. Within rodent models, the
pharmacopeia of KV7 channel modulators has revealed KV7.4
and 7.5 channels are; (1) key determinants of resting vascular tone
via regulation of resting membrane potential; (2) upregulated
during cGMP and cAMP/EPAC/PKA-mediated vasodilation; (3)
suppressed via PKC-mediated vasoconstriction. Comparatively,
no functional role for KV7.1 has been identified in arteries
(see Barrese et al., 2018b; Byron and Brueggemann, 2018 for
review). A caveat of these observations is a lack of differentiation
between VSMCs and ECs. However, recently KV7 channels were
identified in pig coronary artery ECs (Chen et al., 2016), the
novel findings presented here expand on these findings and
demonstrate KV7 transcript and channel expression, functional
activity and contribution to EC-derived vasodilatory signaling
cascades in rat MA endothelium.
In most arteries, the endothelium and smooth muscle are
electrochemically linked via MEGJs formed from connexin
proteins within heterocellular communicating microdomains
Frontiers in Physiology | www.frontiersin.org 11 December 2020 | Volume 11 | Article 598779
fphys-11-598779 December 1, 2020 Time: 20:29 # 12
Baldwin et al. KV7 Characterization in Rat Endothelium
FIGURE 8 | CCh evoked vasorelaxation is mediated through both eNOS and IKCa/SKCa channels and is partially attenuated by inhibition of KV7 channels upstream
of NO. Both eNOS inhibitor L-nitroarginine methyl ester (L-NAME; 100 µmol-L−1; gray) and IKCa/SKCa channel inhibitors TRAM-34 (1 µmol-L−1)/apamin
(100 nmol-L−1; red, dashed line) significantly attenuated CCh mediated vasorelaxation (n = 5–6; A). The pan KV7 channel inhibitor linopirdine (10 µmol-L−1; gray)
significantly attenuated CCh mediated vasorelaxation (n = 6; B). The KV7.1 channel inhibitor HMR-1556 (10 µmol-L−1; gray) did not modulate CCh-mediated
vasorelaxation (n = 6; C). A combination of non-specific K+ channel inhibitors 4-aminopyridine (4-AP; 1 mmol-L−1) and tetraethylammonium (TEA; 1 mmol-L−1;
gray) did not modulate CCh-mediated vasorelaxation (n = 5; D). Additive attenuation to CCh-evoked relaxation in the presence of TRAM-34 (1 µmol-L−1)/apamin
(100 nmol-L−1) + linopirdine (10 µmol-L−1; gray, dashed line) was observed when compared to vessels pre-incubated in only TRAM34/apamin (gray; n = 5–6; E).
No additive attenuation to CCh evoked vasorelaxation was observed between vessels pre-incubated in L-NAME (100 µmol-L−1) + linopirdine (10 µmol-L−1; gray,
dashed line) when compared with L-NAME (100 µmol-L−1; gray; n = 5; F). SNP-mediated vasorelaxation was no effected by the pan-KV7 channel inhibitor
linopirdine (10 µmol-L−1; gray) when compared to DMSO solvent control (black; G). KV7.2-5 channel activator S-1 was significantly attenuated by pre-incubation
with eNOS inhibitor L-NAME (100 µmol-L−1; gray; n = 5; H). All values are expressed as mean + SEM. A two-way statistical ANOVA with a post hoc Bonferroni test
was used to generate significance values (*, drug v DMSO solvent control; #=Group B vs. Group C) Statistical significance is defined as #/*P < 0.05 (A–H).
present within holes in the IEL (see Sandow et al., 2012 for
review). Via these connections, current injection in to ECs passes
into VSMCs (Sandow et al., 2002) supporting the presence of
such coupling. The present data suggests a potential role for
electrochemical heterocellular communication during KV7.2-5
activator-mediated vasorelaxation (Figure 9). This conjecture is
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FIGURE 9 | Schematic of KV7.2-5 activator-mediated vasorelaxation. KV7.2-5 activator-mediated vasorelaxation occurs predominantly via KV7.4/7.5 activation
within VSMCs. However, our findings suggest a novel contribution of endothelial-KV7.4/7.5 channels to KV7.2-5 activator mediated responses which augments
relaxation. A process which is sensitive to both gap-junction and endothelial-KIR2.x inhibition (modified from Senadheera et al., 2012).
supported by apparently higher level expression of KV7.4/KV7.5
in a proportion of IEL holes than that at the EC membrane as
well as a significant attenuation of relaxation of pre-constricted
arterial tone by two structurally different KV7.2-5 activators
in the absence of ECs and presence of a (putative) gap
junction inhibitor. In contrast, EC removal had no impact on
KV7.1 activator-mediated vasorelaxation, which was observed in
conjunction with reduced expression of Kcnq1 transcript and
KV7.1 labeling within ECs compared to VSMCs. Collectively
suggesting that only KV7.4/KV7.5 channels of the KV7 sub-family
are functionally expressed within MA ECs. An extrapolation of
these results indicates a novel role for KV7.4/KV7.5 channels in
the regulation of EC membrane potential within myoendothelial
projections. It is plausible, that localized EC KV7 channels
negate the influx of depolarization from VSMCs into the
endothelium, providing tight regulation of EC Vm during VSMC
contraction. However, further studies would be required to
validate this hypothesis.
A Novel Functional Interaction With
Endothelial KIR Channels
KIR2.x channels have been characterized in a variety of rat
vascular beds including cerebral and coronary arteries (Smith
et al., 2008), where their selective inhibition by Ba2+ revealed
KIR channel amplification of a K+ channel activator conductance
(Smith et al., 2008). However, there is a degree of conflict
regarding the role of KIR2.x channels within rat MAs. As
above, Ba2+ sensitive currents and KIR2.x expression has been
demonstrated in rat MA ECs (Crane et al., 2003a) which
are purported to contribute to KCa mediated-hyperpolarization
during ACh-derived EC-dependent responses (Goto et al., 2004).
In contrast, Smith et al. (2008) demonstrated that within
3rd order MAs, ACh-mediated K+ conductance-dependent
relaxation was insensitive to Ba2+, indicating that KIR2.x
channels do not augment K+ conductance in these vessels during
receptor-mediated vasodilation.
In the present study, significant attenuation of both S-1 and
ML213 KV7.2-5 activator-mediated vasorelaxation was found
following pre-incubation with two structurally different KIR2.x
blockers ML133 (Wu et al., 2010) and Ba2+ (Hagiwara et al.,
1978) when compared to a solvent control. ML133 has been
identified via high-throughput and mutagenesis investigation as
a novel inhibitor of KIR2.1 channels via D172 and I176 residues
within the M2 region of KIR2.1 (Wang et al., 2011) with an IC50
of 1.8 µmol-L−1 at pH 7.4, with little to no effect against other
KIR2.x family members (Wu et al., 2010; Wang et al., 2011).
Presently, ML133 is the most selective inhibitor of the KIR2
family. In analogous fashion to our endothelium denudation
experiments, no effect was seen on the KV7.1 activator ML277-
mediated vasorelaxation; implying a specific interplay with KV7.4
and 7.5 channels. Furthermore, KIR2 blockers had no effect on
KV7.2–7.5 activator-mediated relaxation in EC-denuded arteries,
supporting the notion that functional KIR2 channels (in the rat
MA bed) are restricted to the endothelium (Crane et al., 2003b).
The present study suggests that pharmacological activation of
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endothelial KV7.4/7.5 channels also activates an endothelial KIR2
channels, increasing K+ conductance, which in turn accounts for
a proportion of EC augmentation of KV7.2-5 activator-mediated
vasorelaxation (Figure 9). This may be due to a localized increase
in potassium ion concentration in the proximity of the KIR2
channels or an alternative modulation. However, based on the
findings described by Goto et al. (2004) and Smith et al. (2008),
the collective data suggest that this phenomenon is dependent
on the branch order of MA. Furthermore, it remains unclear
if this occurs during receptor mediated signaling, or if it is
only present during pharmacological activation of endothelial
KV7 channels.
A primary concern for identification of novel functional
interactions between ion channels using pharmacological tools
is potential off-target effects. However, KV7 activator-mediated
relaxation in vessels pre-incubated in 10 µmol-L−1 linopirdine
was abolished. If S-1 or ML213 were activating non-KV channels
such as KIR, a degree of relaxation would still be observed
in the presence of linopirdine. The present findings therefore
suggest that both S-1 and ML213 work exclusively via KV7
channels and that attenuation of their response within rat
MA occurs via a novel functional coupling of KV7.4/7.5 and
KIR2 within ECs.
The Contribution of KV7 Channels to
CCh Evoked Relaxations Within Rat MA
Our findings demonstrate that both NO- and EDH-dependent
signaling contributes to CCh-mediated vasodilation, though the
main contributor to endothelial-dependent vasodilation in 2nd
order MA appears to be EDH, consistent with previous studies
(Shimokawa et al., 1996). In light of the significant impact
of KV7 inhibition on CCh-mediated vasorelaxation during the
suppression of EDH, the present study suggests that KV7
channels contribute to the eNOS sensitive axis of CCh-evoked
relaxation within rat MA.
However, in a similar manner to rat renal artery (Stott et al.,
2015), rat MA KV7 channels do not represent downstream
targets of NO signaling as KV7 inhibition does not impair NO-
donor SNP-mediated relaxation. However, eNOS inhibition does
impair relaxation to a KV7 activator, potentially implying KV7
channel involvement in the production or release of NO in
response to CCh. Interestingly, this appears to be a vascular bed
specific phenomenon, as L-NAME has no effect on KV7 activator-
mediated relaxation within rat penile artery (Jepps et al., 2016).
Limitations
Ideally, direct functional evidence for a functional role of
Kv7 channels in ECs would be provided by either single cell
electrophysiology of sharp microelectrode impalement in whole
arteries. However, this was not possible within the constraints
of this study. Instead, we inferred a functional role for EC
Kv7 channels using a reductive approach, i.e., comparison of
functional responses without or with EC ablation. These studies
implicate Kv7 channels as functional component of the EC
physiology that merit consideration in future studies.
CONCLUSION
In conclusion, the present data reveal that mesenteric
ECs express KV7.4/KV7.5 channels and their presence
boosts KV7 activator-mediated relaxation. Furthermore,
the data indicated a novel functional interaction with
endothelial KIR2 channels and support the proposition
that endothelial KV7 channels contribute to endogenous
endothelium-derived responses. These findings highlight the
complex nature of the vascular response to KV7 channel
upregulation and emphasize the importance of these channels
to vascular signaling. The present data are consistent with
KV7 channels representing a novel therapeutic target in
endothelial dysfunction.
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